Health Care & Life Sciences » Pharmaceuticals | Kaken Pharmaceutical Co. Ltd.

Kaken Pharmaceutical Co. Ltd. | Balance Sheet

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
17,456
24,767
41,744
43,766
52,694
58,555
Total Accounts Receivable
25,361
28,204
29,868
28,231
33,315
30,340
Inventories
13,220
13,482
14,506
16,495
16,651
13,719
Other Current Assets
2,464
2,563
2,873
1,999
2,392
1,114
Total Current Assets
58,501
69,016
88,991
90,494
105,055
103,731
Net Property, Plant & Equipment
28,516
25,961
26,726
26,271
26,141
26,402
Total Investments and Advances
10,994
15,357
14,400
15,943
18,488
17,068
Intangible Assets
598
474
371
372
552
551
Other Assets
2,268
1,101
1,184
1,091
1,753
5,295
Total Assets
106,465
115,135
132,991
135,060
152,417
158,106
ST Debt & Current Portion LT Debt
4,195
4,195
3,875
3,875
3,875
Accounts Payable
13,713
12,295
12,256
11,161
13,452
Income Tax Payable
3,628
3,807
8,628
3,049
5,097
Other Current Liabilities
6,520
10,072
9,102
5,935
8,977
Total Current Liabilities
28,056
30,369
33,861
24,020
31,401
Provision for Risks & Charges
9,496
7,162
8,898
8,029
6,787
Deferred Taxes
5,453
3,105
1,319
887
426
Other Liabilities
682
383
357
355
354
Total Liabilities
38,369
38,035
43,116
32,404
38,542
Common Equity (Total)
68,096
77,100
89,875
102,655
113,874
Total Shareholders' Equity
68,096
77,100
89,875
102,655
113,874
Total Equity
68,096
77,100
89,875
102,655
113,874
Liabilities & Shareholders' Equity
106,465
115,135
132,991
135,059
152,416

About Kaken Pharmaceutical Co.

View Profile
Address
2-28-8 Honkomagome
Tokyo Tokyo 113
Japan
Employees -
Website http://www.kaken.co.jp
Updated 07/08/2019
Kaken Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products, medical devices, agrochemicals, and animal health products in Japan. Its operations are carried out through the following business divisions: Pharmaceuticals and Medical Devices, Agrochemicals and Animal Health Products, Overseas Activity, Research & Development, and Licensing Opportunities. The Pharmaceuticals and Medical Devices division offers artz(anti-osteoarthritis), clenafin (topical onychomycosis treatment product), seprafilm (anti-adhesive absorbent barrier), lipidil (anti-hyperlipidemia product), fiblast spray (wound-healing product), mentax (anti-trichophyton product) and generic drugs.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.